SKI Market

Indian Indices

Sensex

82,970.28 -704.64
( -0.84%)

Global Indices

Nasdaq

49,462.85 -679.56
(-1.36%)

Dow Jones

6,851.97 -110.50
(-1.59%)

Hang Seng

57,686.98 36.44
(0.06%)

Nikkei 225

10,413.72 -58.39
(-0.56%)

Forex

USD-INR

90.66 0.06
(0.07%)

EUR-INR

107.82 -0.02
(-0.02%)

GBP-INR

123.81 -0.01
(0.00%)

JPY-INR

0.59 0.01
(1.13%)

YOU ARE HERE :
HOME
Markets
Equity
Company News

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

532331

INE031B01049

330.3875196

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AJANTPHARM

38.28

36093.9

EPS(TTM)

Face Value()

Div & Yield %

75.48

0.97

Date	Headline
30-Jan-2026	Ajanta Pharma consolidated net profit rises 17.56% in the December 2025 quarter
12-Jan-2026	Ajanta Pharma to table results
02-Jan-2026	Ajanta Pharma Ltd spurts 0.34%, gains for five straight sessions
31-Dec-2025	Ajanta Pharma Ltd gains for third straight session
24-Dec-2025	Volumes jump at JBM Auto Ltd counter
24-Dec-2025	Volumes soar at Castrol India Ltd counter
04-Dec-2025	Ajanta Pharma Ltd soars 0.12%, up for fifth straight session
02-Dec-2025	Ajanta Pharma Ltd rises for third straight session
06-Nov-2025	Ajanta Pharma Ltd - Ajanta Pharma Limited - Analysts/Institutional Investor Meet/Con. Call Updates
03-Nov-2025	Board of Ajanta Pharma recommends interim dividend

<< < 1 2 3 ... > >>

82,970.28 -704.64 ( -0.84%)

49,462.85 -679.56 (-1.36%)

6,851.97 -110.50 (-1.59%)

57,686.98 36.44 (0.06%)

10,413.72 -58.39 (-0.56%)

90.66 0.06 (0.07%)

107.82 -0.02 (-0.02%)

123.81 -0.01 (0.00%)

0.59 0.01 (1.13%)